ADMA Biologics, Inc. reported the retirement of CFO Brad Tade on February 20, 2026, effective February 25, 2026, and the promotion of Terry Kohler to CFO starting February 26, 2026. Tade will consult for the company at a monthly fee of $41,666.67, and Kohler, formerly Executive Financial Advisor, has a base salary of $500,000 with performance bonuses.